Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 1998

View Archived Issues

Health Canada gives the go-ahead for clinical testing of TH-9402

Millennium, Wyeth-Ayerst identify another CNS gene target

Fuisz and Novopharm enter agreements for CEFORM CR technology

Cognition-enhancing and antidepressant agent available from BTG

Intercardia signs license to develop drug for IBD

Hybridon and Searle extend and expand antisense research collaboration

Novel gamma-aminobutyric acids related to gabapentin prepared at Warner-Lambert

Advanced Viral Research to initiate clinical trials with Reticulose in Mexico

Dainippon's new agents for urinary incontinence

New heterocyclic compounds inhibit cardiac chymase activity

Antiplatelet agents in the pipeline at Boehringer Ingelheim

Daiichi patents compounds for enhancing bacterial sensitivity to antimicrobial agents

Cypress Bioscience files PMA for Prosorba Column

AIT-082: a new neuroregenerative compound

Effects of RGH-2716 on neurotransmitter release and cerebral energy metabolism

Mechanism of action, anxiolytic and anticonvulsant activity of AWD-131-138

NDA filed for magainin antibiotic for infected diabetic foot ulcers

Biogen: Q2 1998 highlights

Multiyear drug delivery agreement signed by Bioglan and Novo Nordisk

Dura acquires U.S. marketing rights to Myambutol

Cel-Sci, U of Maryland receive state funding for TB test

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...